Emory University School of Medicine
Dr. Alanna A. Morris joined the ECCRI faculty in 2013. Dr. Morris received her undergraduate degree in Biology from Xavier University of Louisiana, and her medical degree from the Harvard Medical School. She completed her residency at Brigham and Womens Hospital in Boston, Massachusetts. Subsequently, she came to Emory University to complete fellowships in general cardiology, and advanced heart failure and transplant. After completion of her fellowship training, she was appointed Assistant Professor of Medicine in the Division of Cardiology at Emory University School of Medicine, and spends her clinical time in the Emory Center for Heart Failure Therapy and Transplantation. She serves as the the Director of Heart Failure Research, and the Associate Program Director of the Clinical Investigator Track of the Cardiovascular Disease Fellowship Program.
Dr. Morris research interests include studying the importance of non-modifiable risk factors such as race and gender that may contribute to excess disease in high risk populations, and identifying the role of biomarkers of oxidative stress (OS) and endothelial dysfunction in patients with heart failure with reduced ejection fraction (HFrEF). Her research examines the interface between biochemical markers of OS with vascular and endothelial dysfunction in HFrEF, and the importance of metabolomic signatures in determining HF progression. In particular, she also seeks to define race- and gender- based differences in these biochemical and vascular markers, and whether they contribute significantly to observed differences in HF morbidity and mortality. Finally, her research examines race- and gender-based differences in outcomes after heart transplantation and LVAD implantation.